Dow Down 0.25% Nasdaq Down 0.26%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
51.96 0.07(0.13%) Aug 28, 4:00PM EDT
Prev Close:52.03
Open:51.60
Bid:48.51 x 100
Ask:55.25 x 100
1y Target Est:84.80
Beta:1.23
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:51.20 - 53.67
52wk Range:39.75 - 80.42
Volume:349,395
Avg Vol (3m):389,080
Market Cap:1.08B
P/E (ttm):89.13
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 0.13%1.08B
LLY67.63B
MRK173.08B
RHHBY248.42B

Key Statistics

Forward P/E (1 yr):21.38
P/S (ttm):19.91
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.55
Quarterly EPS Est (Sep-14) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback